雨水
SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
Jieyu
Lv1
42 积分
2023-10-16 加入
最近求助
最近应助
互助留言
Flaring Among Atopic Dermatitis Patients – The Perception of Flaring Burden Between Physicians and Patients
9天前
已完结
Clinical features and biomarker differences of severe intrinsic and extrinsic atopic dermatitis
1个月前
已完结
Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab
1个月前
已完结
A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics
2个月前
已完结
Exacerbating factors of itch in atopic dermatitis
2个月前
已完结
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation
2个月前
已完结
中国中重度特应性皮炎诊疗临床路径专家共识(2023版)
2个月前
已完结
Treatment of atopic dermatitis with dupilumab in Taiwan: dynamic changes of IgE levels as a potential response biomarker
2个月前
已关闭
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
2个月前
已完结
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation
2个月前
已完结
没有进行任何应助
帮大忙了
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论